Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Busam

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Head & Neck|March 14, 2002
Primary mucosal malignant melanoma of the head and neckSnehal G Patel, Manju L Prasad, Margarita Escrig, et al.
The American Journal of Surgical Pathology|March 12, 2025
A Clinical, Morphologic, and Molecular Comparison of Bonafide Spitz Melanomas and ASTs in the Pediatric PopulationHaya Mary Beydoun, Julia Edwin Jeyakumar, Afua Addo, et al.
Journal of the National Cancer Institute|December 5, 2002
HDM2 protein overexpression and prognosis in primary malignant melanomaDavid Polsky, Kate Melzer, Carole Hazan, et al.
Annals of Surgical Oncology|May 18, 2013
Immunological insights from patients undergoing surgery on ipilimumab for metastatic melanomaDavid E Gyorki, Jianda Yuan, Zhenyu Mu, et al.
British Journal of Haematology|August 3, 2006
Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response?John Gerecitano, Andre Goy, John Wright, et al.
BMC Medical Genetics|March 10, 2007
Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanomaJavier Cotignola, Boris Reva, Nandita Mitra, et al.
Genes, Chromosomes & Cancer|June 3, 2015
Consistent copy number changes and recurrent PRKAR1A mutations distinguish Melanotic Schwannomas from Melanomas: SNP-array and next generation sequencing analysisLu Wang, Ahmet Zehir, Justyna Sadowska, et al.
Cancer Immunology, Immunotherapy : CII|April 6, 2011
CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three casesJianda Yuan, Brian Ginsberg, David Page, et al.
The American Journal of Dermatopathology|November 23, 2007
Consumption of the epidermis: a criterion in the differential diagnosis of melanoma and dysplastic nevi that is associated with increasing breslow depth and ulcerationRuth Fulghum Walters, Pamela A Groben, Klaus Busam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Classification of clear-cell sarcoma as a subtype of melanoma by genomic profilingNeil H Segal, Paul Pavlidis, William S Noble, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Head & Neck|March 14, 2002
Primary mucosal malignant melanoma of the head and neckSnehal G Patel, Manju L Prasad, Margarita Escrig, et al.
The American Journal of Surgical Pathology|March 12, 2025
A Clinical, Morphologic, and Molecular Comparison of Bonafide Spitz Melanomas and ASTs in the Pediatric PopulationHaya Mary Beydoun, Julia Edwin Jeyakumar, Afua Addo, et al.
Journal of the National Cancer Institute|December 5, 2002
HDM2 protein overexpression and prognosis in primary malignant melanomaDavid Polsky, Kate Melzer, Carole Hazan, et al.
Annals of Surgical Oncology|May 18, 2013
Immunological insights from patients undergoing surgery on ipilimumab for metastatic melanomaDavid E Gyorki, Jianda Yuan, Zhenyu Mu, et al.
British Journal of Haematology|August 3, 2006
Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response?John Gerecitano, Andre Goy, John Wright, et al.
BMC Medical Genetics|March 10, 2007
Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanomaJavier Cotignola, Boris Reva, Nandita Mitra, et al.
Genes, Chromosomes & Cancer|June 3, 2015
Consistent copy number changes and recurrent PRKAR1A mutations distinguish Melanotic Schwannomas from Melanomas: SNP-array and next generation sequencing analysisLu Wang, Ahmet Zehir, Justyna Sadowska, et al.
Cancer Immunology, Immunotherapy : CII|April 6, 2011
CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three casesJianda Yuan, Brian Ginsberg, David Page, et al.
The American Journal of Dermatopathology|November 23, 2007
Consumption of the epidermis: a criterion in the differential diagnosis of melanoma and dysplastic nevi that is associated with increasing breslow depth and ulcerationRuth Fulghum Walters, Pamela A Groben, Klaus Busam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Classification of clear-cell sarcoma as a subtype of melanoma by genomic profilingNeil H Segal, Paul Pavlidis, William S Noble, et al.
Pageof 10